A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease (Movement Disorders, 2017)

(untitled) - Marrinan, S; Otiker, T; Vasist, L; Gibson, R; Sarai, B; Barton, M; Richards, D; Hellström, P; Nyholm, D; Dukes, G; Burn, D